Patents by Inventor Yossi Gross

Yossi Gross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210370065
    Abstract: Apparatus (20, 420) is provided that includes a retinal implant (40), configured for implantation on a retina (306) of a subject's eye (300) in an epi-retinal position; and an anchor (60, 460, 660) shaped to define (i) an anterior portion (70, 470, 670), (ii) a posterior portion (90, 490, 690) coupled to the retinal implant (40), and (iii) a middle portion (80, 480, 680) extending longitudinally between the anterior portion (70, 470, 670) and the posterior portion (90, 490, 690). The anchor (60, 460, 660) is configured to anchor the retinal implant (40) to the retina (306) such that when the retinal implant (40) is implanted on the retina (306), the anterior portion (70, 470, 670) of the anchor (60, 460, 660) is mounted against a ciliary sulcus (310) of the eye (300). Other embodiments are also described.
    Type: Application
    Filed: May 1, 2019
    Publication date: December 2, 2021
    Applicant: Nano-Retina LTD.
    Inventors: Rani MENDELEWICZ, David RIGLER, Yossi GROSS, Ben SAAR, Yaakov MILSTAIN, Dorit RAZ PRAG, Boris DEGTIAR, Daniel SHAKI, Ofir RIMER-COHEN, Tsachi CZACZKES
  • Publication number: 20210361839
    Abstract: Apparatus is provided, including a flexible intraventricular receptacle positionable within a heart ventricle, and configured to assume a first volume upon passage of fluid that is not blood into the receptacle and a second, smaller volume upon passage of the fluid out of the receptacle. An expandable extracardiac receptacle is positionable outside of the heart, and is configured to expand upon transfer of the fluid into the extracardiac receptacle from the intraventricular receptacle and to contract upon passage the fluid out of the extracardiac receptacle. A transmyocardial conduit is disposed and allows passage of the fluid between the intraventricular receptacle and the extracardiac receptacle responsively to a cardiac cycle. During ventricular systole, a volume of fluid is expelled from the intraventricular receptacle, through the conduit, and the extracardiac receptacle, producing a corresponding decrease in a total volume of the ventricle during isovolumetric contraction of the ventricle.
    Type: Application
    Filed: May 20, 2020
    Publication date: November 25, 2021
    Applicant: RAINBOW MEDICAL LTD.
    Inventor: Yossi GROSS
  • Publication number: 20210361946
    Abstract: An excitation unit is configured to induce action potentials by applying an excitatory current to a nerve. A blocking unit is configured to block the induced action potentials from propagating along the nerve by applying a blocking current to the nerve. A sensor unit is configured to detect the induced action potentials in the nerve, and to responsively provide a sensor signal that conveys information about the detected induced action potentials. Circuitry is configured (i) to drive the excitation unit to apply the excitatory current, (ii) to drive the blocking unit to apply the blocking current, (iii) while driving the blocking unit to apply the blocking current, to drive the sensor unit to detect the induced action potentials and provide the sensor signal, (iv) to receive the sensor signal, and (v) in response to the sensor signal, to alter a parameter of the blocking current.
    Type: Application
    Filed: August 4, 2021
    Publication date: November 25, 2021
    Applicant: BLUEWIND MEDICAL LTD.
    Inventors: Gur ORON, Bar EYTAN, Eran BENJAMIN, Anton PLOTKIN, Yossi GROSS
  • Publication number: 20210361422
    Abstract: A method includes advancing apparatus including a core toward a patient's heart valve. The core tapers in a distal direction toward the smallest perimeter of the core. The apparatus includes a first ventricular arm, which is articulatable with respect to a first atrial arm at a first articulation site, and a second ventricular arm, which is articulatable with respect to a second atrial arm at a second articulation site. The articulation sites are adjacent to the smallest perimeter. The tapering of the core defines a minimum nonzero angle of the atrial arms with respect to a central longitudinal axis of the core. The method also includes clamping the first and second leaflets between the respective atrial arms and the respective ventricular arms. Other embodiments are also described.
    Type: Application
    Filed: August 5, 2021
    Publication date: November 25, 2021
    Applicant: CARDIOVALVE LTD.
    Inventors: Yossi GROSS, Gil Hacohen
  • Publication number: 20210361937
    Abstract: Apparatus is provided for treating an intervertebral disc of a subject, the apparatus including at least one intra-pulposus exposed electrode surface, which is configured to be implanted in a nucleus pulposus of the intervertebral disc; and one or more extra-pulposus exposed electrode surfaces, which are configured to be implanted outside the nucleus pulposus, in electrical communication with the intervertebral disc. Control circuitry is electrically coupled to the at least one intra-pulposus exposed electrode surface and one or more extra-pulposus exposed electrode surfaces. The control circuitry is configured to treat disc herniation by applying a voltage of less than 1.2 V between the at least one intra-pulposus exposed electrode surface and the one or more extra-pulposus exposed electrode surfaces. Other embodiments are also described.
    Type: Application
    Filed: August 4, 2021
    Publication date: November 25, 2021
    Applicant: RAINBOW MEDICAL LTD.
    Inventor: Yossi GROSS
  • Publication number: 20210353937
    Abstract: An electrode is provided that includes a wire that has a wire diameter of between 75 and 125 microns. The electrode includes a non-electrically-insulated current-application longitudinal segment, which, in the absence of any applied forces, is coiled and has (i) an outer coil diameter of between 3 and 7 times the wire diameter, and (ii) an entire longitudinal length of between 5 and 35 mm. The electrode further includes an electrically-insulated lead longitudinal segment, which has an entire longitudinal length of at least 10 mm, in the absence of any applied forces. Other embodiments are also described.
    Type: Application
    Filed: July 28, 2021
    Publication date: November 18, 2021
    Applicant: RAINBOW MEDICAL LTD.
    Inventors: Yossi GROSS, Zev Sohn
  • Publication number: 20210338426
    Abstract: An implant is configured to be coupled to first and second native leaflets of a native heart valve of a patient. The implant includes a proximal collar, a distal collar, and first and second clasps. Each of the first and second clasps has first and second tissue-engaging portions that are (1) disposed distal to the proximal collar and proximal to the distal collar, and (2) movable, with respect to each other, to clamp one of the leaflets between the first and second tissue-engaging portions of the clasp. The implant is configured such that, when the leaflets are clamped by the first and second clasps, the first and second clasps form the first and second native leaflets into a double orifice, each orifice configured to function as a respective check-valve. Other embodiments are also described.
    Type: Application
    Filed: June 1, 2021
    Publication date: November 4, 2021
    Applicant: CARDIOVALVE LTD.
    Inventors: Yossi GROSS, Gil HACOHEN
  • Patent number: 11160459
    Abstract: Methods and systems for monitoring health status of chronically ill people are provided. An example system includes a wearable device with sensors, with the wearable device being designed to be worn on a wrist of a patient. The wearable device is operable to continuously collect, via sensors, sensor data from a single place on body of the patient. The sensor data are processed to obtain electrocardiogram data and photoplethysmogram data. The electrocardiogram data and the photoplethysmogram data are analyzed to obtain medical parameters associated with a chronic disease. Based at least partially on the changes in the medical parameters over time, a progression of the at least one chronic disease can be determined. Based on the progression, messages regarding the current health condition are sent to the patient. The messages include advice to take medicine or contact a medical professional if a chronic condition is worsening.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: November 2, 2021
    Assignee: ChroniSense Medical Ltd.
    Inventors: Yossi Gross, Daniel H. Lange
  • Publication number: 20210330456
    Abstract: Implantable first atrial and ventricular arms are articulatable at a first articulation site to clamp a first heart valve leaflet. A first elongate transitioning member is (a) connected at a fixed connection point at a portion of the first ventricular arm farthest from the first articulation site, (b) has a portion that faces an opposite surface of the first ventricular arm, and (c) is controllable to move the first ventricular arm. Implantable second atrial and ventricular arms are articulatable at a second articulation site to clamp a second leaflet. A second elongate transitioning member is (a) connected at a fixed connection point at a portion of the second ventricular arm farthest from the second articulation site, (b) has a portion that faces an opposite surface of the second ventricular arm, and (c) is controllable to move the second ventricular arm. Other embodiments are also described.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 28, 2021
    Applicant: CARDIOVALVE LTD.
    Inventors: Gil Hacohen, Yossi Gross
  • Patent number: 11147955
    Abstract: Embodiments are disclosed of a method of controlling timing and/or dosage of a transdermal drug patch. For example, a control device operative to move the patch to one or more of a plurality of operational relationships with a skin of a patient, including being fully engaged with the skin, partially engaged with the skin, and disengaged with the skin. The device may include a roller that peels a patch on and off the skin. Optionally a convention patch is used. In some embodiments a patch and/or an adaptor has a mobile zone and an immobile zone. In some embodiments, an active surface of the patch fully contacts the skin in an engaged state. For example the patch may be attached to the device on a passive portion thereof.
    Type: Grant
    Filed: February 18, 2016
    Date of Patent: October 19, 2021
    Assignee: Alma Therapeutics Ltd.
    Inventors: Yossi Gross, Oz Cabiri, Ran Hezkiahu
  • Publication number: 20210315698
    Abstract: An implant is configured to be coupled to first and second native leaflets of a native heart valve of a patient. The implant includes a proximal collar, a distal collar, and first and second clasps. Each of the first and second clasps has first and second tissue-engaging portions that are (1) disposed distal to the proximal collar and proximal to the distal collar, (2) movable, with respect to each other, to clamp one of the leaflets between the first and second tissue-engaging portions of the clasp, and (3) movable, when clamped to the leaflet, toward and away from a central longitudinal axis of the implant. Other embodiments are also described.
    Type: Application
    Filed: May 3, 2021
    Publication date: October 14, 2021
    Applicant: CARDIOVALVE LTD.
    Inventors: Yossi GROSS, Gil HACOHEN
  • Patent number: 11141588
    Abstract: A method is provided that includes implanting a first electrode in a cerebrospinal fluid (CSF)-filled space of a brain of a subject identified as at risk of or suffering from Alzheimer's disease. One or more second electrodes are implanted superficial to brain parenchyma of the subject, such that the brain parenchyma is spatially disposed between a ventricular system of the brain and the one or more second electrodes. Control circuitry is activated to drive the first and the one or more second electrodes to clear amyloid beta and/or tau protein from the brain parenchyma into the ventricular system by applying current between the first electrode and the one or more second electrodes using an average voltage of less than 1.2 V. Other embodiments are also described.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: October 12, 2021
    Assignee: RAINBOW MEDICAL LTD.
    Inventors: Gideon Fostick, Yossi Gross, Alex Tendler
  • Patent number: 11129981
    Abstract: Apparatus is provided that includes one or more intra-pulposus exposed electrode surfaces, and a support structure along which the one or more intra-pulposus exposed electrode surfaces are disposed. The support structure is configured to be implanted within a nucleus pulposus of an intervertebral disc of a subject, and to be shaped as a partial ring or a complete ring after implantation. The apparatus further includes one or more extra-pulposus exposed electrode surfaces, which are configured to be implanted outside the nucleus pulposus, in electrical communication with the disc. Control circuitry is provided, which is configured to: configure the intra-pulposus exposed electrode surfaces to be cathodes, and the one or more extra-pulposus exposed electrode surfaces to be one or more anodes, and drive the intra-pulposus exposed electrode surfaces and the one or more extra-pulposus exposed electrode surfaces to electroosmotically drive fluid into the nucleus pulposus. Other embodiments are also described.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: September 28, 2021
    Assignee: RAINBOW MEDICAL LTD.
    Inventors: Yossi Gross, Gideon Fostick
  • Patent number: 11123197
    Abstract: An artificial intervertebral disc (IVD) is provided for replacement of a degenerated intervertebral disc. The artificial IVD includes two endplates having oppositely-facing outward surfaces configured to engage respective intervertebral surfaces of the spinal column, and a chamber, which is disposed between oppositely-facing inner surfaces of the two endplates, and which includes a lateral wall including an electroosmotic membrane. A plurality of exposed electrode surface includes (i) one or more intra-chamber exposed electrode surfaces, which are located within the chamber; and (ii) one or more extra-chamber exposed electrode surfaces, which are located outside the chamber, in a vicinity of the chamber. Control circuitry is configured to drive at least one of the one or more intra-chamber exposed electrode surfaces and at least one of the one or more extra-chamber exposed electrode surfaces to electroosmotically drive liquid from outside the chamber to inside the chamber.
    Type: Grant
    Filed: September 3, 2019
    Date of Patent: September 21, 2021
    Assignee: RAINBOW MEDICAL LTD.
    Inventor: Yossi Gross
  • Publication number: 20210283397
    Abstract: A prosthetic aortic valve is provided, which is configured to be delivered to a native aortic valve of a patient in a constrained delivery configuration within a delivery sheath. The prosthetic aortic valve includes a frame, which includes interconnected stent struts arranged so as to define interconnected stent cells; a plurality of prosthetic leaflets coupled to the frame; a cathode and an anode, which are mechanically coupled to the frame; and a prosthetic-valve coil, which is in non-wireless electrical communication with the cathode and the anode, and is coupled to a plurality of the stent struts, running along the stent struts so as to surround a plurality of the stent cells when the prosthetic aortic valve is in an expanded fully-deployed configuration upon release from the delivery sheath. Other embodiments are also described.
    Type: Application
    Filed: May 24, 2021
    Publication date: September 16, 2021
    Applicant: E-VALVE SYSTEMS LTD.
    Inventor: Yossi GROSS
  • Patent number: 11116975
    Abstract: An excitation unit is configured to induce action potentials by applying an excitatory current to a nerve. A blocking unit is configured to block the induced action potentials from propagating along the nerve by applying a blocking current to the nerve. A sensor unit is configured to detect the induced action potentials in the nerve, and to responsively provide a sensor signal that conveys information about the detected induced action potentials. Circuitry is configured (i) to drive the excitation unit to apply the excitatory current, (ii) to drive the blocking unit to apply the blocking current, (iii) while driving the blocking unit to apply the blocking current, to drive the sensor unit to detect the induced action potentials and provide the sensor signal, (iv) to receive the sensor signal, and (v) in response to the sensor signal, to alter a parameter of the blocking current.
    Type: Grant
    Filed: October 22, 2018
    Date of Patent: September 14, 2021
    Assignee: BLUEWIND MEDICAL LTD.
    Inventors: Gur Oron, Bar Eytan, Eran Benjamin, Anton Plotkin, Yossi Gross
  • Patent number: 11097098
    Abstract: A method is provided that includes providing an electrode, which includes a wire that has a wire diameter of between 75 and 125 microns. The wire includes a non-electrically-insulated current-application longitudinal segment, which, in the absence of any applied forces, is coiled and has a mean pitch of between 1.1 and 2 times the wire diameter, and an entire longitudinal length of between 5 and 35 mm. The wire also includes an electrically-insulated lead longitudinal segment has an entire longitudinal length of between 5 and 80 mm, in the absence of any applied forces. At least a portion of the electrode is implanted in a body of a subject. Other embodiments are also described.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: August 24, 2021
    Assignee: RAINBOW MEDICAL LTD.
    Inventors: Yossi Gross, Zev Sohn
  • Publication number: 20210252272
    Abstract: Apparatus is provided that is configured to be deployed in a lumen of a blood vessel of a subject. The apparatus includes a pump portion, including an anchor configured to engage a wall of the blood vessel in order to maintain the apparatus in place within the blood vessel, and a reciprocating valve coupled to the anchor and including a set of one or more leaflets. A valve driver is configured to drive the reciprocating valve in a reciprocating pattern between (i) a first state in which the leaflets are in an open configuration allowing blood flow through the reciprocating valve, and (ii) a second state in which the leaflets are in a closed configuration inhibiting blood flow through the reciprocating valve. Other embodiments are also described.
    Type: Application
    Filed: May 3, 2021
    Publication date: August 19, 2021
    Applicant: RAINBOW MEDICAL LTD.
    Inventor: Yossi GROSS
  • Patent number: 11065451
    Abstract: A prosthetic aortic valve is configured to be delivered to a native aortic valve of a patient in a constrained delivery configuration within a delivery sheath. The prosthetic aortic valve includes a frame; a plurality of prosthetic leaflets coupled to the frame; a cathode and an anode, which are mechanically coupled to the frame; and a prosthetic-valve coil, which is coupled to the frame and is in non-wireless electrical communication with the cathode and the anode. When the prosthetic aortic valve is in an expanded fully-deployed configuration upon release from the delivery sheath, (a) a line defined between upstream-most and downstream-most points of mechanical coupling between the prosthetic-valve coil and the frame and (b) a central longitudinal axis defined by the frame form an angle of between 20 and 70 degrees. Other embodiments are also described.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: July 20, 2021
    Assignee: E-VALVE SYSTEMS LTD.
    Inventor: Yossi Gross
  • Publication number: 20210212572
    Abstract: Apparatus for monitoring a clinical condition of a subject is described. A motion sensor senses motion of the subject without contacting or viewing the subject, and generates a sensed motion signal responsive to the sensed motion. A signal analyzer is adapted to analyze the motion signal to identify a cough in the subject. Other applications are also described.
    Type: Application
    Filed: March 8, 2021
    Publication date: July 15, 2021
    Inventors: Avner HALPERIN, Yossi GROSS